Bacterial Disease Diagnostics Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027

The bacterial disease diagnostics market is estimated to decline at a CAGR of 6.28% between 2022 and 2027. The size of the market is forecast to increase by USD 3,766.05 million. The growth of the market depends on serval factors, including the integration of digital health in rapid diagnostics for bacterial disease, the high prevalence of infectious diseases, and the growing number of merger and acquisition (M&A) activities. 

This report extensively covers market segmentation by product (consumables and instruments), end-user (hospitals and labs), and geography (North America, Europe, Asia, and Rest of World). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the size of the Bacterial Disease Diagnostics Market During the Forecast Period?

To learn more about this report, Download Report Sample

Parent Market Analysis

Technavio categorizes the global bacterial disease diagnostics market as a part of the pharmaceutical market within the overall healthcare industry. The parent pharmaceuticals market covers products and companies engaged in the R&D or production of generic drugs, non-generic drugs, and veterinary drugs.  Our research report has extensively covered external factors influencing the parent market growth during the forecast period.

Bacterial Disease Diagnostics Market: Key Drivers, Trends, Challenges, and Customer Landscape

The high prevalence of infectious diseases is notably driving the market growth, although factors such as the lack of accessibility to bacterial diagnostic tests in developing countries may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Bacterial Disease Diagnostics Market Driver

The high prevalence of infectious diseases is notably driving the infectious disease diagnostics market growth.  Globally, infectious disease outbreaks have increased due to changing lifestyles, which led to reduced immunity. The pattern of infection incidence has also been changing with the evolution of drug-resistant pathogens. The increasing prevalence of infectious diseases is expected to boost market growth as it increases the need for initiatives to increase disease awareness. Awareness campaigns about the identification of signs and symptoms of infectious diseases and methods of prevention play an important role in preventing the spread of infections.

Furthermore, the impact of these infectious diseases varies globally from region to region, with Sub-Saharan Africa, Asia Pacific, Latin America, and the Middle East getting impacted the most due to factors such as malnutrition, poor sanitation, poor water quality, and lack of proper healthcare systems. Therefore, medical professionals use bacterial disease diagnostic products such as instruments, kits, and reagents for the detection of various pathogenic organisms such as bacteria and viruses. Hence, such factors will increase the demand for bacterial disease diagnostics, which will drive the growth of the market during the forecast period.

Significant Bacterial Disease Diagnostics Market Trend

The growing demand for portable analytical instruments is an emerging trend in the infectious disease diagnostics market. Portable laboratory instruments are increasingly gaining prominence in the field of diagnostics owing to their ease of use. These portable instruments offer real-time, direct, and on-site measurements of inorganic and organic analytes in samples on the field, unlike conventional instruments that are ineffective on-field tools, as they do not accommodate easy movement of the instrument from the laboratory to the field. 

Portable PCR systems provide an on-site screening option to laboratory technicians and researchers. Also, these systems enable the subsequent selection of samples for routine laboratory analysis to maximize the accuracy of results. This is because the field analyst can carry the PCR systems to the site where the real-time data results are shared within hours, and the respective health or safety concerns are addressed immediately, which makes PCR systems more effective when compared with their benchtop counterparts. Furthermore, portable instruments provide a rapid and accurate diagnosis of various bacterial infections and determine the presence of antibiotic-resistant bacterial strains. Hence, such factors will augment the growth of the global infectious disease diagnostics market during the forecast period.

Major Bacterial Disease Diagnostics Market Challenge

The lack of accessibility to bacterial diagnostic tests in developing countries is a major challenge impeding infectious disease diagnostics market growth. High-quality diagnostic tests are easily available for various bacterial diseases in the majority of developed countries. However, they are not easily affordable or accessible in developing countries, where the disease burden is high. Management of disease by addressing symptoms is ineffective and increases the risk of antibiotic resistance. Therefore, evidence-based treatment is needed along with proper bacterial disease diagnosis for efficient disease management and developing therapies. 

A few of the barriers to the global market in developing countries include a lack of financial investment and market knowledge and support from local governments, lack of local expertise, lack of quality standards for diagnostic test evaluation and clear regulatory approvals, increased competition from vendors supplying cheaper imports, and lack of cost-efficient manufacturing process, among others. Therefore, the above-mentioned issues are expected to hamper the growth of the market during the forecast period.

Key Bacterial Disease Diagnostics Market Customer Landscape

The report includes the adoption lifecycle of the infectious disease diagnostics market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Bacterial Disease Diagnostics Market Customer Landscape

Who are the Major Bacterial Disease Diagnostics Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the infectious disease diagnostics market.

QIAGEN NV - The company operates under one segment. The company under this segment focuses on providing services related to sample technologies, diagnostic solutions, nucleic acid amplification, and genomics. The key offerings of the company include bacterial disease diagnostics. 

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

• Abbott Laboratories
• Accelerate Diagnostics Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• bioMerieux SA
• Bruker Corp.
• Danaher Corp.
• DiaSorin SpA
• EKF Diagnostics Holdings Plc
• F. Hoffmann La Roche Ltd.
• GENERI BIOTECH s.r.o.
• Great Basin Scientific
• Hologic Inc.
• Meridian Bioscience Inc.
• Perkin Elmer Inc.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Bacterial Disease Diagnostics Market?

The market share growth by the consumables segment will be significant during the forecast period. The consumables segment comprises test kits, assays, and reagents used for the quantification of bacterial diseases. It contributes significantly to the market growth due to the repetitive purchase of a broad range of PCR consumables for different testing purposes.

Get a glance at the market contribution of various segments Request a PDF Sample

The consumables segment was valued at USD 4,333.50 million in 2017 and continued to grow until 2021. End-users use consumables such as reagents and buffers repeatedly to conduct tests and experiments. Various applications require a variety of reagents based on the purpose of testing, which provides an opportunity for PCR consumables manufacturers to offer a broad range of consumables to meet the testing requirements of end-users. The high demand for consumables is further augmented by the ever-changing consumer demands, resulting in shifting diagnostic testing from hospitals and laboratories to patients' homes, which reduces the cost of testing. Furthermore, technological advances in reaction buffers have provided greater stability and longer activity for reagents and enzymes, which resulted in enhancing the value of PCR and reverse transcription-polymerase chain reaction (RT-PCR) techniques. In addition, advances in the microarray, which provides the genetic (deoxyribonucleic acid (DNA) analysis in a short period, have contributed to the success of testing and experimenting. Therefore, such factors are anticipated to drive the growth of the market during the forecast period. 

Which are the Key Regions for the Bacterial Disease Diagnostics Market?

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 49% to the growth of the global infectious disease diagnostics market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The US is the leading contributor to the market in North America, owing to the growing focus on the treatment of bacterial diseases such as TB. The major factors associated with the market growth in North America are the increase in the prevalence of bacterial diseases such as TB, meningitis, and pneumonia. Respiratory tract infections caused by bacteria are among the most common conditions in human beings and are associated with a high economic burden. In Canada, researchers have developed new methods to diagnose a bacterial infection. For instance, the University of British Columbia Okanagan campus and the University of Calgary for the development of a diagnostic tool that aids healthcare practitioners in performing on-spot diagnosis of a bacterial infection. It offers a rapid, label-free, and contactless diagnosis and also screens the interaction of bacteria with antibiotics. Moreover, the total healthcare spending in Canada increased significantly and reached approximately USD 515 billion by the first half of 2022. Furthermore, there is a significant increase in the prevalence of chronic diseases in the region. The development of such diagnostic tests will be helpful for patients with chronic infections, which in turn, will fuel the market growth during the forecast period. 

Furthermore, the development of new antibacterial drugs and the increase in funding for the development of new therapies for the treatment of infectious diseases are the major factors that drive market growth. Similarly, organizations such as the Biomedical Advanced Research and Development Authority (BARDA), under the US Department of Health and Human Services office, support and fund the development of new anthrax vaccines. Such developments are expected to drive market growth in the region during the forecast period.

In 2020, the market was severely affected by the outbreak of COVID-19. However, the lifting of lockdowns due to the initiation of vaccination drives in 2021 increased the number of scheduled medical procedures and treatments, including the treatment for bacterial diseases. This has raised the demand for bacterial disease diagnostic techniques. The increasing adoption of technologically advanced bacterial disease diagnostic techniques, the rising prevalence of bacterial diseases, and the growing healthcare expenditures are expected to drive the growth of the regional market during the forecast period.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

• Product Outlook (USD Million, 2017 - 2027)
  • Consumables
  • Instruments

• End-user Outlook (USD Million, 2017 - 2027)
  • Hospitals
  • Labs

• Region Outlook (USD Million, 2017 - 2027)
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
    • Vietnam
    • Others
  • Rest of World
    • Saudi Arabia
    • South Africa
    • Brazil
    • Others

Bacterial Disease Diagnostics Market Scope
Report Coverage	Details
Page number	165
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Decelerate at a CAGR of 6.28%
Market growth 2023-2027	USD 3,766.05 million
Market structure	Fragmented
YoY growth 2022-2023(%)	5.67
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 49%
Key countries	US, Canada, Germany, UK, and Japan
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., Perkin Elmer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Bacterial Disease Diagnostics Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the bacterial disease diagnostics market between 2023 and 2027
• Precise estimation of the size of the bacterial disease diagnostics market size and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of bacterial disease diagnostics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch